8-K filing — Inogen Inc (INGN)
Filed: 2026-09-30 AccNo: 0001294133-26-000037 Size: 195 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Full Transcript: Inogen Q2 2026 Earnings Call
Inogen (NASDAQ:INGN) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Inogen Agrees To Divest Its U.S. Oxygen Rental Operations To Rotech Healthcare For $25M
Top 3 Health Care Stocks That Could Blast Off This Month
The health care sector's oversold stocks present buying opportunities for undervalued companies. RSI compares stock strength on up and down days, with an RSI below 30 considered oversold.